Tu-Liang Liang
Guangzhou University of Chinese Medicine(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Immunotherapy and Biomarkers, Autophagy in Disease and Therapy, Sphingolipid Metabolism and Signaling, Immune cells in cancer
Most-Cited Works
- → Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling(2021)100 cited
- → The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance(2022)84 cited
- → Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response(2022)78 cited
- → Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa(2021)61 cited
- → CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer(2023)22 cited
- → Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging(2025)17 cited
- → Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment(2024)16 cited
- → A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy(2021)14 cited
- → Taurine and proline promote lung tumour growth by co-regulating Azgp1/mTOR signalling pathway(2025)6 cited